Blood–brain barrier delivery of protein and non-viral gene therapeutics with molecular Trojan horses
- 8 October 2007
- journal article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 122 (3), 345-348
- https://doi.org/10.1016/j.jconrel.2007.04.001
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Fusion Antibody for Alzheimer's Disease with Bidirectional Transport Across the Blood−Brain Barrier and Aβ Fibril DisaggregationBioconjugate Chemistry, 2007
- Genetic engineering, expression, and activity of a fusion protein of a human neurotrophin and a molecular Trojan horse for delivery across the human blood–brain barrierBiotechnology & Bioengineering, 2007
- Humanization of anti‐human insulin receptor antibody for drug targeting across the human blood–brain barrierBiotechnology & Bioengineering, 2006
- Delivery of β-Galactosidase to Mouse Brain via the Blood-Brain Barrier Transferrin ReceptorThe Journal of pharmacology and experimental therapeutics, 2005
- Imaging Gene Expression in Regional Brain Ischemia In Vivo with a Targeted [111In]-Antisense RadiopharmaceuticalMolecular Imaging, 2004
- Intravenous RNA Interference Gene Therapy Targeting the Human Epidermal Growth Factor Receptor Prolongs Survival in Intracranial Brain CancerClinical Cancer Research, 2004
- Imaging Brain Amyloid of Alzheimer Diseasein Vivoin Transgenic Mice with an Aβ Peptide RadiopharmaceuticalJournal of Cerebral Blood Flow & Metabolism, 2002
- Neuroprotection in Transient Focal Brain Ischemia After Delayed Intravenous Administration of Brain-Derived Neurotrophic Factor Conjugated to a Blood-Brain Barrier Drug Targeting SystemStroke, 2001
- Delayed Treatment with Intravenous Basic Fibroblast Growth Factor Reduces Infarct Size following Permanent Focal Cerebral Ischemia in RatsJournal of Cerebral Blood Flow & Metabolism, 1995
- Brain-Derived Neurotrophic Factor Protects against Ischemic Cell Damage in Rat HippocampusJournal of Cerebral Blood Flow & Metabolism, 1994